The Department of Veterans Affairs, Network Contracting Office 19, is conducting market research to identify sources for Polymerase Chain Reaction (PCR) molecular virology testing at the Oklahoma City VA Healthcare System. This notice seeks to determine the availability of contractors to provide automated molecular virology instruments and all necessary components on a Cost Per Test (CPT), Cost Per Reportable Result (CPRR), or Cost Per Kit (CPK) basis. The requirement involves one contractor-owned analyzer capable of performing In-Vitro Diagnostic PCR tests with minimal hands-on time. The testing menu includes Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), Human Papilloma Virus (HPV), Chlamydia Trachomatis/Neisseria Gonorrhoeae (CT/NG), and Trichomoniasis Vaginalis/Mycoplasma Genitalium (TV/MG). The pricing model is intended to be fully inclusive, covering the equipment, maintenance, software and hardware upgrades, workstations, servers, training, quality control, reagents, and all necessary consumables. Capability statements and completed market research questionnaires are due by June 26, 2026. Submissions are limited to eight pages and should include a solution overview, business size information, and feedback on NAICS code 334516. The Department of Veterans Affairs is conducting market research for PCR molecular virology testing at the Oklahoma City VA Healthcare System. This RFI evaluates industry capability to provide a comprehensive testing solution on a Cost Per Test, Cost Per Reportable Result, or Cost Per Kit basis. The agency is seeking information on contractor-owned automated instruments and the support required for diagnostic results. NCO 19 is evaluating the market for PCR molecular virology testing services at the…
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.
Contact and place of performance
Ernest Appiah
Oklahoma City 73104
Sources Sought Notice Polymerase Chain Reaction (PCR)-Molecular Virology Testing Disclaimer: This Request for Information (RFI) is issued solely for market research information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. Responses to this notice are NOT offers and cannot be accepted by the Gov...
View more